Expression profile of circular RNAs in type 2 diabetes mellitus patients with retinopathy
Journal of Diabetes Investigation · 2026
DOI: 10.1111/jdi.70241 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes Investigation, 2026. Verfasst von Wencheng An und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Beijing Haidian Hospital, Beijing Haidian Section of Peking University Third Hospital, Beijing, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetic Retinopathy, RNA, Circular, Biomarkers. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Bethune-Merck Diabetes Research Foundation.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims/Introduction Diabetic retinopathy (DR) is a prevalent chronic complication of type 2 diabetes mellitus (T2DM), contributing significantly to vision impairment. Circular RNAs (circRNAs) have emerged as key regulators in the pathogenesis of DR. This study aimed to investigate the differential expression profiles and potential functions of circRNAs in patients with DR compared to those without DR. Materials and Methods In this single‐center, prospective study, serum samples from 20 T2DM patients with DR and 20 without DR were analyzed using the Arraystar Human circRNA Expression Profile V2.0 microarray. An additional cohort of 40 patients (20 DR and 20 without DR) was used to validate selected circRNAs via quantitative reverse transcription PCR (qRT‐PCR). Enriched signaling pathways were identified using Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses. CircRNA–miRNA–mRNA interaction networks were constructed using bioinformatics tools.
Results
A total of 376 circRNAs were differentially expressed, including 169 upregulated and 207 downregulated circRNAs. qRT‐PCR validation confirmed five downregulated circRNAs and three upregulated circRNAs, which were selected for competing endogenous RNA analysis. The circRNA–miRNA–mRNA network analysis revealed that hsa_circRNA_407262 (also known as circRNA LOC389906) may act as a miRNA sponge regulating key signaling pathways, including wingless/integrated, gonadotropin‐releasing hormone, tumor necrosis factor, and rat sarcoma pathways.
Conclusions
This study identified five downregulated and three upregulated circRNAs associated with DR. Among them, hsa_circRNA_407262 may play a crucial role in the pathological process of DR and holds potential as a candidate biomarker for early diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Beijing Haidian Hospital, Beijing Haidian Section of Peking University Third Hospital, Beijing, China.
- Department of General Surgery, Peking University Third Hospital, Beijing, China.
ORCID-Profile: Zhijun Cui, Huixian Yan
Förderung
- Bethune-Merck Diabetes Research Foundation
Zitieren
APA
An, W., Wang, B., Chen, F., An, B., Zhou, S., Jiang, L., Cui, Z., Ou, X., Huang, W., & Yan, H. (2026). Expression profile of circular RNAs in type 2 diabetes mellitus patients with retinopathy. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.70241
Vancouver
An W, Wang B, Chen F, An B, Zhou S, Jiang L, et al. Expression profile of circular RNAs in type 2 diabetes mellitus patients with retinopathy. Journal of Diabetes Investigation. 2026. doi:10.1111/jdi.70241
BibTeX
@article{An2026,
author = {An, Wencheng and Wang, Bingyan and Chen, Fang and An, Bo and Zhou, Shujing and Jiang, Lin and Cui, Zhijun and Ou, Xiaohong and Huang, Wei and Yan, Huixian},
title = {Expression profile of circular RNAs in type 2 diabetes mellitus patients with retinopathy},
journal = {Journal of Diabetes Investigation},
year = {2026},
doi = {10.1111/jdi.70241}
}
EUVIMED